|
HY-14121-50mg
|
MedChemexpress LLC
|
MRS 1754 [CAS 264622-58-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-14121-1mL
|
MedChemexpress LLC
|
MRS 1754 [CAS 264622-58-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-124543-10mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-100mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-25mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-5mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-50mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-1mL
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103174-10mg
|
MedChemexpress LLC
|
MRS1334 [CAS 192053-05-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103174-5mg
|
MedChemexpress LLC
|
MRS1334 [CAS 192053-05-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-10mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-100mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-25mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-5mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-50mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-1mL
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-145962A-10mg
|
MedChemexpress LLC
|
MRTX-EX185 (formic)
|
|
Cancer-Kinase/protease
|
|
|
HY-145962A-5mg
|
MedChemexpress LLC
|
MRTX-EX185 (formic)
|
|
Cancer-Kinase/protease
|
|
|
HY-132301-10mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-100mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-25mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-5mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-50mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-1mL
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P701103-10ug
|
MedChemexpress LLC
|
MSP/MST1, Mouse (C677A, HEK293)
|
|
|
|
